Question: Peter Robert Voser was the CEO from July 2009 to December 2013 to a company headquartered in which country ?

Context articles: Joey (Sugarland song)
Science Applications International Corporation
Leandro Bueno Bergantin
Peter Wheeler (TVR)
2009 flu pandemic in Malaysia
Funmedia
Royal Dutch Shell
Sutro Biopharma
Homosexuality in India
Peter Voser

"Joey" is a song co-written and recorded by American country music duo Sugarland.
 The duo's two members, Jennifer Nettles and Kristian Bush, wrote it along with country singer Bill Anderson.
 It was released in July 2009 as the fourth single from the duo's album "Love on the Inside".
 Sugarland's twelfth single release, it debuted at number 50 on the "Billboard" Hot Country Songs charts in July 2009.
Science Applications International Corporation (SAIC) is an American company headquartered in Reston, Virginia that provides government services and information technology support.
 The original SAIC was created in 1969 by J. Robert Beyster.
 Then on September 27, 2013, it spun off a $4 billion unit which retained its name, while the parent company changed its name to Leidos.
 Following the split, Anthony J. Moraco was appointed CEO of SAIC, and John P. Jumper was appointed CEO of Leidos.
 The primary motivation for the spinoff was the conflicts of interest provisions in the Federal Acquisition Regulations which prevented the company from bidding on some new contracts because of existing contracts.
Leandro Bueno Bergantin is a PhD from the Universidade Federal de São Paulo and the primary author of a paper on the discovery of the "calcium paradox" in sympathetic transmission.
Dr. Bergantin received his academic education at EPM-UNIFESP (Brazil) and UAM (Spain): degree in biomedicine (2008), MSc (2010) and PhD (2014).
 His research involves cell signaling mediated by Ca2+ and cAMP, skeletal and smooth muscles, peripheral and central nervous systems.
 His research work solved the enigma of the paradoxical effects produced by L-type Ca2+ channel blockers (TOP 25 Hottest Articles - Biochemistry, Genetics and Molecular Biology - Cell Calcium - TOP 1 July to September 2013/ TOP 5 October to December 2013/ TOP 1 January to December 2013 full year/TOP 6 January to March 2014).
 Since 1975, several clinical and experimental studies have reported that acute and chronic administration of L-type voltage-activated Ca2+ channels (VACCs) blockers, such as nifedipine, produces reduction in arterial pressure associated with an increase of sympathetic activity.
 Despite this sympathetic hyperactivity has been initially attributed to adjust reflex of arterial pressure, the cellular and molecular mechanisms involved in this apparent sympathomimetic effect of the L-type VACCs blockers remained unclear for decades.
 In 2013, Dr. Bergantin and collaborators discovered that this paradoxical increase in sympathetic activity produced by L-type VACCs blockers is due to interaction of the Ca2+/cAMP signaling pathways.
 Then, the pharmacological manipulation of the Ca2+/cAMP interaction produced by combination of the L-type VACCs blockers used in the antihypertensive therapy, and cAMP accumulating compounds used in the antidepressive therapy, could represent a potential cardiovascular risk for hypertensive patients due to increase in sympathetic activity.
 In contrast, this pharmacological manipulation could be a new therapeutic strategy for increasing neurotransmission in psychiatric disorders, and producing neuroprotection in the neurodegenerative diseases.
 The original article was listed as a "hot article" (TOP 1 July to September 2013/TOP 5 October to December 2013/TOP 1 January to December 2013 full year) in ScienceDirect.
Peter Robert Wheeler (29 February 1944 – 11 June 2009) was a chemical engineer from Sheffield, Yorkshire, UK, who owned the Blackpool-based TVR sports car company for 23 years.
The 2009 flu outbreak in Malaysia is part of a larger flu pandemic involving a new type of influenza A virus subtype H1N1 (A (H1N1)) virus.
 As of 11 August 2009, the country has over 2,253 cases, beginning with "imported" cases from affected countries, including the United States and Australia from 15 May 2009 onwards, and the first identified local transmission on 17 June 2009.
 From 12 August, the Malaysian Health Ministry said that it had discontinue officially updating the total number of H1N1 cases within Malaysia in line with guidelines issued by the World Health Organisation.
 As of 21 August 2009 the unofficial number of cases reported in the media is 5,876 so far.
 The first death related to the A(H1N1) virus was reported on 23 July 2009 and so far there have been 78 deaths reported.
 On 6 July 2009 Malaysia announced that it was shifting from containment to mitigation to tackle the spread of the virus.
 The federal government has declared a national health emergency in Malaysia because of the A(H1N1) outbreak and is considering imposing a health curfew similar to the week-long shutdown of non-essential services and industries in Mexico.
Funmedia Sp.
 z o.o. (previously named FunEnglish.pl) - Polish e-learning company headquartered in Wrocław.
 The company was founded on 10 July 2009 by two graduates of Wrocław University of Economics - Bartłomiej Postek and Krzysztof Wojewodzic.
 In 2011, as the first company in Poland, Funmedia received accreditation from the Ministry of National Education for its first online English coursebook for children.
 Since 5 August 2013, Funmedia has been a member of PIIT.
Royal Dutch Shell plc (, ), commonly known as Shell, is a British–Dutch multinational oil and gas company headquartered in the Netherlands and incorporated in the United Kingdom.
 It is one of the six oil and gas "supermajors" and the sixth-largest company in the world measured by 2016 revenues (and the largest based in Europe).
 Shell was first in the 2013 Fortune Global 500 list of the world's largest companies; in that year its revenues were equivalent to 84% of the Netherlands' $556 billion GDP.
Sutro Biopharma is a private biopharmaceutical company headquartered in South San Francisco that develops antibody-drug conjugate and multi-specific antibody-based therapeutics for cancer therapy.
 Founded in 2003 under the name Fundamental Applied Biology, the company name changed to Sutro Biopharma in 2009.
 The current CEO, William Newell, joined Sutro in January 2009.
 Newell has over 15 years of senior management experience in the biotechnology industry, and has worked for companies such as Aerovance, QLT, Inc., and Ayxs Pharmaceuticals, Inc.
 Sutro’s CFO, Edward Albini, previously worked at Itero Biopharmaceuticals, Novacea, and Lynx Therapeutics.
 The CSO, Trevor Hallam, formerly worked at Palatin Technologies, AstraZeneca, Glaxo Group Research, and Roche Research Centre.
 The company received $26M in Series D funding in December 2013.
 The company’s investors include Alta Partners, Skyline Ventures, SV Life Sciences, Lilly Ventures, Amgen Ventures and Celgene.
Homosexuality is mostly a taboo subject in Indian civil society and for the government.
 Section 377 of the Indian Penal Code makes sex with persons of the same gender punishable by law.
 On 2 July 2009, in "Naz Foundation v. Govt.
 of NCT of Delhi", the Delhi High Court held that provision to be unconstitutional with respect to sex between consenting adults, but the Supreme Court of India overturned that ruling on 11 December 2013, stating that the court was instead deferring to Indian legislators to provide the sought-after clarity.
 On 2 February 2016, however, the Supreme Court agreed to reconsider its judgment, stating it would refer petitions to abolish Section 377 to a five-member constitutional bench, which would conduct a comprehensive hearing of the issue.
Peter Robert Voser (born 29 August 1958) is a Swiss businessman.
 He served as the CEO of Royal Dutch Shell plc from July 2009 to December 2013.
 He started his career at Royal Dutch Shell in 1982, working in a number of finance and business roles in different countries.
 Between 2002 and 2005 he served as chief financial officer for ABB.
 In 2004, he was appointed Shell’s chief financial officer (CFO) and then CEO in July 2009.
 In April 2015, he was elected as chairman of ABB's board of directors.